These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1904163)

  • 1. [Protective effect of misoprostol on the changes of transgastric potential difference induced by aspirin in man].
    Bergmann JF; Simoneau G; Naudin R; Caulin C; Segrestaa JM
    Rev Rhum Mal Osteoartic; 1991 Feb; 58(2):135-8. PubMed ID: 1904163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prophylactic effect of Misoprostol on gastric lesions induced by aspirin (ASA) in healthy subjects].
    Naves J; Santoyo R; Morales I
    Rev Gastroenterol Mex; 1989; 54(4):203-6. PubMed ID: 2515571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misoprostol attenuates aspirin-induced changes in potential difference and associated damage in canine gastric mucosa.
    Gullikson GW; Anglin CP; Kessler LK; Smeach S; Bauer RF; Dajani EZ
    Clin Invest Med; 1987 May; 10(3):145-51. PubMed ID: 3113798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapeutic efficacy of misoprostol in peptic ulcer disease.
    Watkinson G; Hopkins A; Akbar FA
    Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration.
    Lanza F; Peace K; Gustitus L; Rack MF; Dickson B
    Am J Gastroenterol; 1988 Feb; 83(2):143-6. PubMed ID: 3124604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, placebo-controlled, 6-day evaluation of two doses of misoprostol in gastroduodenal mucosal protection against damage from aspirin and effect on bowel habits.
    Lanza FL; Kochman RL; Geis GS; Rack EM; Deysach LG
    Am J Gastroenterol; 1991 Dec; 86(12):1743-8. PubMed ID: 1962619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects against alcohol insult: does somatostatin play any role?
    Agrawal NM; Godiwala T; Arimura A; Groot K; Dajani E
    Postgrad Med J; 1988; 64 Suppl 1():15-20. PubMed ID: 2901743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Misoprostol heals gastroduodenal injury in patients with rheumatoid arthritis receiving aspirin.
    Roth S; Agrawal N; Mahowald M; Montoya H; Robbins D; Miller S; Nutting E; Woods E; Crager M; Nissen C
    Arch Intern Med; 1989 Apr; 149(4):775-9. PubMed ID: 2495779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute injury to the gastric mucosa by acetylsalicylic acid. A comparative endoscopic study in man with oral prostaglandin analogs, omeprazole and ranitidine].
    Müller P; Dammann HG; Simon B
    Arzneimittelforschung; 1986 Feb; 36(2):265-8. PubMed ID: 3083829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind placebo-controlled comparison of the efficacy and safety of 50, 100, and 200 micrograms of misoprostol QID in the prevention of ibuprofen-induced gastric and duodenal mucosal lesions and symptoms.
    Lanza FL; Fakouhi D; Rubin A; Davis RE; Rack MF; Nissen C; Geis S
    Am J Gastroenterol; 1989 Jun; 84(6):633-6. PubMed ID: 2499187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric protection by misoprostol against 1300 mg of aspirin. An endoscopic study.
    Silverstein FE; Kimmey MB; Saunders DR; Levine DS
    Dig Dis Sci; 1986 Feb; 31(2 Suppl):137S-141S. PubMed ID: 3080286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of the mucosal protective effects of misoprostol in man.
    Dajani EZ
    Prostaglandins; 1987; 33 Suppl():117-29. PubMed ID: 3122272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of the acetylsalicylic acid-induced changes of the gastric potential difference by the new synthetic prostaglandin E1 analogue rioprostil.
    Demol P; Schmitz HD; Weihrauch TR; Kuhlmann J
    Arzneimittelforschung; 1986 Sep; 36(9):1406-8. PubMed ID: 3098255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Misoprostol and gastroduodenal mucosal protection (cytoprotection).
    Wilson DE
    Postgrad Med J; 1988; 64 Suppl 1():7-11. PubMed ID: 3138683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric antisecretory and cytoprotective activity of MDL 646, a 16-methyl-16-methoxy prostaglandin E1 analog in man.
    Petrillo M; Lazzaroni M; Fuccella L; Sassella D; Bianchi Porro G
    Hepatogastroenterology; 1987 Jun; 34(3):117-9. PubMed ID: 3610017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misoprostol: a prostaglandin for peptic ulcer.
    DiPalma JR
    Am Fam Physician; 1989 Aug; 40(2):217-9. PubMed ID: 2502901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An alprostadil analogue and human gastric secretion. A double-blind placebo-controlled study of the effects of a tablet and lyovial formulation.
    Müller P; Dammann HG; Simon B
    Arzneimittelforschung; 1987 Aug; 37(8):972-4. PubMed ID: 3675697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric protection by misoprostol against 1,300 mg of aspirin. An endoscopic dose-response study.
    Silverstein FE; Kimmey MB; Saunders DR; Surawicz CM; Willson RA; Silverman BA
    Am J Med; 1987 Jul; 83(1A):32-6. PubMed ID: 3113243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal cytoprotective effects of misoprostol. Clinical efficacy overview.
    Dajani EZ; Nissen CH
    Dig Dis Sci; 1985 Nov; 30(11 Suppl):194S-200S. PubMed ID: 3932054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of gastric mucosa by sucralfate from aspirin-induced erosions.
    Tesler MA; Lim ES
    J Clin Gastroenterol; 1981; 3(Suppl 2):175-9. PubMed ID: 6895645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.